Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Neural Regulation01:37

Neural Regulation

44.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presymptomatic late-onset Pompe disease: Optimizing the timing of treatment.

Revue neurologique·2025
Same author

Homozygous DNAJB4 deletion revealing myopathy with acute respiratory failure.

Revue neurologique·2025
Same author

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique·2025
Same author

Autosomal dominant distal myopathy due to p.Ser85Cys mutation in the MATR3 gene: Novel case series and literature review.

Revue neurologique·2025
Same author

NETest® 2.0-A decade of innovation in neuroendocrine tumor diagnostics.

Journal of neuroendocrinology·2025
Same author

<i>ARID1B</i>-related disorder in 87 adults: Natural history and self-sustainability.

Genetics in medicine open·2024

Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

Alzheimer disease: modeling an Aβ-centered biological network.

D Campion1,2,3,4, C Pottier1,4, G Nicolas1,2,4,5

  • 1Inserm U1079, Rouen University, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.

Molecular Psychiatry
|March 30, 2016
PubMed
Summary

Researchers are exploring rare genetic variants to understand complex diseases like Alzheimer's disease (AD). Network-based analyses of genes involved in amyloid beta (Aβ) pathways offer a promising approach for genetic studies.

More Related Videos

Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.8K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.5K

Related Experiment Videos

Last Updated: Mar 23, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.8K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.5K

Area of Science:

  • Genetics
  • Neuroscience
  • Computational Biology

Background:

  • Genetically complex diseases often involve rare variants with significant effects, necessitating advanced analytical methods beyond traditional gene-level analysis.
  • The amyloid cascade hypothesis posits that amyloid beta (Aβ) peptide drives Alzheimer's disease (AD) pathology.
  • Next-generation sequencing enables genome-wide characterization of rare variants, but gene-level aggregation may lack statistical power.

Purpose of the Study:

  • To identify and catalog genes and proteins implicated in the biological network of Alzheimer's disease (AD) related to amyloid beta (Aβ).
  • To provide a comprehensive list of AD-associated genes and proteins, classified by cellular function, for use in genetic studies.

Main Methods:

  • Manual curation of scientific literature to identify proteins interacting with amyloid beta (Aβ) in its production, clearance, aggregation, or toxicity.
  • Classification of identified genes/proteins based on their cellular functions within the AD biological network.

Main Results:

  • Identification of 335 genes/proteins involved in the amyloid beta (Aβ) biological network in Alzheimer's disease (AD).
  • Categorization of these genes/proteins according to their specific cellular functions.

Conclusions:

  • Network-based analyses, focusing on genes involved in Aβ pathways, are valuable complements to classical genetic approaches for complex diseases like AD.
  • The curated list of 335 genes/proteins provides a valuable resource for ongoing and future genetic studies in Alzheimer's disease.